Akums - About the company
Akums is a public company based in Delhi (India), founded in 2004 by Sandeep Jain and Sanjeev Jain. It operates as a CDMO focusing on spectrum of dosage forms and therapeutic segments. Akums has raised $70M in funding from Quadria Capital. The company has 877 active competitors, including 26 funded and 138 that have exited. Its top competitors include companies like Rubicon, Jubilant Life Sciences and Recipharm.
Company Details
CDMO focusing on spectrum of dosage forms and therapeutic segments. It also manufactures and exports formulations in various dosage forms include oral solids, oral liquids, sterile, hormonal, ointments, cosmetics, Ayurvedic, and nutraceuticals. And also across a wide spectrum of other therapeutic segments, include respiratory, neurology, analgesics, cardiovascular, immunomodulators, and supportive care.
- Website
- www.akums.in/
- Email ID
- *****@akums.net
- Registered Address
- Unit 101, Plot No.4, 1st Floor, Mohan Place LSC, Block-C, Saraswati Vihar, North West, Delhi, Delhi, India, 110034
Key Metrics
Founded Year
2004
Location
Delhi, India
Stage
Public
Total Funding
$70M in 1 round
Latest Funding Round
Investors
Ranked
1st among 877 active competitors
Annual Revenue
₹4,170Cr as on Mar 31, 2025
Employee Count
395 as on Oct 31, 2024
Investment & Acquisitions
Exit Details
Public
Legal entities associated with Akums
Akums is associated with 9 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
MALIK LIFESCIENCES PRIVATE LIMITED CIN: U63021DL2004PTC299408 , India, Active | Feb 05, 2004 | $70.4M (As on Mar 31, 2025) | 400 (As on Jan 31, 2025) | |
AKUMS DRUGS AND PHARMACEUTICALS LIMITED CIN: L24239DL2004PLC125888 , India, Active | Apr 19, 2004 | $493M (As on Mar 31, 2025) | 1611 (As on Aug 01, 2025) | |
AVHA LIFESCIENCES PRIVATE LIMITED CIN: U51909DL2017PTC325425 , India, Active | Oct 30, 2017 | $1.75K (As on Mar 31, 2025) | 1 (As on Mar 31, 2022) | |
AKUMS LIFESCIENCES LIMITED CIN: U24231CH1996PLC017755 , India, Active | Feb 22, 1996 | $27.7M (As on Mar 31, 2023) | - | |
AKUMS HEALTHCARE LIMITED CIN: U24304DL2020PLC375098 , India, Active | Dec 29, 2020 | $6.32M (As on Mar 31, 2025) | 230 (As on Jan 31, 2025) | |
MEDIBOX PHARMA PRIVATE LIMITED CIN: U72900DL2016PTC399490 , India, Active | Aug 19, 2016 | $2.62M (As on Mar 31, 2025) | - | |
MAXCURE NUTRAVEDICS LIMITED CIN: U74899DL1994PLC057323 , India, Active | Feb 10, 1994 | $71.1M (As on Mar 31, 2025) | 199 (As on Aug 01, 2025) | |
AKOME LIFECARE PRIVATE LIMITED CIN: U24100DL2022PTC393711 , India, Active | Feb 11, 2022 | $1.7M (As on Mar 31, 2025) | - | |
AKUMS FOUNDATION CIN: U85300DL2019NPL355543 , India, Active | Sep 25, 2019 | $157K (As on Mar 31, 2025) | - |
Akums's IPO details
Akums got listed on Aug 06, 2024.
Click here to take a look at Akums's IPO in detail
Sign up to download Akums' company profile
Akums's funding and investors
Akums has raised a total funding of $70M over 1 round. Its latest funding round was a PE round on Nov 13, 2019 for $*****. 1 investor participated in its latest round. Akums has 1 institutional investor and 5 angel investors.
Here is the list of recent funding rounds of Akums:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 13, 2019 | 1308676 | PE | 1348310 | 7665866 | 3908993 | 8456333 |
View details of Akums's funding rounds and investors
Akums' founders and board of directors
Founder? Claim ProfileThe founders of Akums are Sandeep Jain and Sanjeev Jain.
Here are the details of Akums' key team members:
- Sandeep Jain: Co-Founder & MD of Akums and founder of 1 other company. They are also an angel investor in 11 startups and serve on the boards of 2 companies.Contact Info: 1 email address
- Sanjeev Jain: Co-Founder and Director of Akums. They are also an angel investor in 2 startups and serve on the boards of 4 companies.Contact Info: 1 phone number
Akums' Board of Directors
Akums's board has 7 active members. Sandeep Jain, Sanjeev Jain, Vijaypal Singh Rawat and Neena Vivek are part of team and Nand Lal, Neena Mohan and Narendra Dev are independent board members.Here is the list of Akums' board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 21y 10m | |
mgaxrey | Team | - | Past | 4y 3m |
mbryhuk | Team | - | Current | 8y 5m |
wcemi{q | Team | - | Current | 5y 2m |
etkymwt | Team | - | Past | 9y 7m |
Independent board member | - | Current | 13y 9m | |
qthwb{g | Independent board member | - | Current | 4y 5m |
avqsfma | Independent board member | - | Current | 5y 2m |
elxblft | Independent board member | - | Past | 6y 9m |
wspsuix | Independent board member | - | Past | 8y 5m |
vwzafhy | Independent board member | - | Past | 6y 8m |
rykoeoo | Independent board member | - | Past | 8y 7m |
View details of Akums's Founder profiles and Board Members
Akums' employee count trend
Akums has 395 employees as of Oct 24. The total employee count is 5.0% more than what it was in Oct 23. Here is Akums's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Akums's Competitors and alternates
Top competitors of Akums include Rubicon, Jubilant Life Sciences and Recipharm. Here is the list of Top 10 competitors of Akums, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | CDMO focusing on spectrum of dosage forms and therapeutic segments | $70M | 60/100 | ||
2nd | CDMO offering drug development services through its proprietary drug delivery technologies | $4.62M | 60/100 | ||
3rd | Jubilant Life Sciences 1978, Noida (India), Public | Company offering a suite of R&D and manufacturing services for small molecules and generics | - | 59/100 | |
4th | Contract services for pharmaceutical development and manufacturing | - | 57/100 | ||
5th | Nivagen Pharmaceuticals 2009, Sacramento (United States), Acquired | Developer and contract manufacturer of generic drugs, tablets, capsules, ointment and solution | $31M | 56/100 | |
6th | Nectar Lifesciences 1995, Chandigarh (India), Public | Manufacturer of cephalosporin APIs and generic formulations | $46.9M | 56/100 | |
7th | Ipca Laboratories 1949, Mumbai (India), Public | Manufacturer of pharmaceutical formulations, active pharmaceutical ingredients, and generic medications | - | 56/100 | |
8th | SAVA group 2003, Pune (India), Unfunded | Pharma company with a portfolio of domestic and export products, also offering CRAMS services | - | - | 55/100 |
9th | Supriya Lifescience 2008, Mumbai (India), Public | Manufacturer of active pharmaceutical ingredients and finished dosage formulations for healthcare | - | - | 54/100 |
10th | Halo Pharma 2006, Hanover (United States), Acquired | CDMO offering integrated drug development services | $25M | 53/100 |
Looking for more details on Akums's competitors? Click here to see the top ones
Akums's Investments and acquisitions
Akums has made 3 investments in companies including Medibox and Medibox. Akums has also acquired 2 companies including Ankur Drugs and Parabolic Drugs.Here is the list of investments & acquisitions:
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Apr 26, 2022 | Acquisition | 1997 | Mumbai (India) | |
Sep 14, 2019 | Investments | 2016 | Bengaluru (India) | |
Apr 2019 | Acquisition | 1996 | Chandigarh (India) |
News related to Akums
Media has covered Akums for a total of 10 events in the last 1 year, 3 of them have been about company updates and 1 about partnerships.
•
Akums Secures EU GMP Certification for Two Manufacturing Facilities in IndiaContract Pharma•Feb 23, 2026•Akums
•
•
•
Akums Drugs & Pharmaceuticals receives ANVISA GMP certification for sterile plantIndiaMedToday•Jul 28, 2025•Akums
•
•
Akums Drugs Invests in 600 kW Rooftop Solar System for SustainabilityMercom India•Apr 09, 2025•Akums
•
•
Akums launches Ripasudil + Timolol combination for glaucoma treatment and ocular hypertensionBioSpectrum India•Apr 01, 2025•Akums
•
Akums paving way for greener future with rooftop solar power plantBioSpectrum India•Mar 28, 2025•Akums
•
Akums Signs Mou With Niftem-tIndiaMedToday•Mar 04, 2025•Akums, National Institute of Food Technology, Entrepreneurship and Management
Are you a Founder ?
FAQs about Akums
Explore our recently published companies
- Elearningvoices - United Kingdom based, 2017 founded, Unfunded company
- Electricgaterepairlondon - United Kingdom based, 2016 founded, Unfunded company
- Easterndrainageservices - United Kingdom based, Unfunded company
- Eastbudleighshop - United Kingdom based, Unfunded company
- Chrisburnscatering - United Kingdom based, Unfunded company
- Christinedoyle - United Kingdom based, Unfunded company